No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis
Open Access
- 8 October 2019
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 147 (1) , 76-83
Abstract
Previous studies on the risk of cancer after total hip arthroplasty (THA) contradict each other, and many are hampered by small cohort sizes, residual confounding, short observation times, or a mix of indications underlying the THA procedure. We evaluated the risk of cancer after total hip arthroplasty due to osteoarthritis in a nationwide cohort by comparing cancer incidences in individuals exposed to total hip arthroplasty due to osteoarthritis and in unexposed, sex‐, age‐ and residence matched individuals. To address some previous studies' shortcomings, information on comorbidity and socioeconomic background was obtained and adjusted for. We included 126,276 patients exposed to a cemented THA between 1992 and 2012, and 555,757 unexposed individuals. Follow‐up started on the day of surgery for exposed individuals and respective date for matched, unexposed individuals, and ended on the day of death, emigration, censuring, or December 31st 2012, whichever came first. The Swedish Hip Arthroplasty Registry (SHAR), the Swedish Cancer Registry, the Swedish National Patient Registry and Statistics Sweden were accessed to obtain information on procedural details of the THA, cancer diagnoses, comorbidities, and socioeconomic background. The primary outcome measure was the occurrence of any cancer after the index date. Exposed individuals had a slightly lower adjusted risk of developing any cancer than unexposed individuals (hazard ratio [HR] 0.97; CI 0.95 ‐ 0.99). The only cancer with a statistically significantly risk increase in exposed individuals was skin melanoma (HR 1.15; CI 1.05 ‐ 1.24). We attained similar risk estimates in analyses stratified by sex, in individuals with minimum 5 years of follow‐up, in an analysis including individuals with a history of previous cancer, and in patients with cementless THA. In this study on a large and well‐defined population with long follow‐up, we found no increased overall risk of cancer after THA. These reassuring findings could be included in the guidelines on pre‐operative information given to THA patients.Keywords
This publication has 38 references indexed in Scilit:
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Cancer risk is not increased after conventional hip arthroplastyActa Orthopaedica, 2010
- Elevated Serum Concentrations of Cobalt, Chromium, Nickel, and Manganese After Metal-On-Metal Alloarthroplasty of the Hip: A Prospective Randomized StudyThe Journal of Arthroplasty, 2009
- Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosisActa Orthopaedica, 2003
- Outcome after total hip arthroplasty: Part II. Disease-specific follow-up and the Swedish National Total Hip Arthroplasty RegisterActa Orthopaedica, 2001
- Cancer incidence in finnish hip replacement patients from 1980 to 1995The Journal of Arthroplasty, 1999
- Preliminary Observations on Possible Premalignant Changes in Bone Marrow Adjacent to Worn Total Hip Arthroplasty ImplantsClinical Orthopaedics and Related Research, 1996
- Cancer Risk After Hip Replacement With Metal Implants: a Population-Based Cohort Study in SwedenJNCI: Journal of the National Cancer Institute, 1995
- Cobalt, chromium, and nickel concentrations in body fluids of patients with porous‐coated knee or hip prosthesesJournal of Orthopaedic Research, 1989
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987